Skip to main content
Journal cover image

Polyvascular disease and increased risk of cardiovascular events in patients with type 2 diabetes: Insights from the EXSCEL trial.

Publication ,  Journal Article
Samsky, MD; Mentz, RJ; Stebbins, A; Lokhnygina, Y; Aday, AW; Pagidipati, NJ; Jones, WS; Katona, BG; Patel, MR; Holman, RR; Hernandez, AF ...
Published in: Atherosclerosis
December 2021

BACKGROUND AND AIMS: Polyvascular disease is an independent predictor of major adverse cardiovascular events (MACE). The relationship between the number of diseased arterial beds and MACE is unknown. How MACE risk changes in individuals with type 2 diabetes (T2D) is also understudied. Furthermore, it is unknown whether heart failure (HF) status and hemoglobin A1c (HbA1c) levels influence outcomes in polyvascular disease. This analysis from the Exenatide Study of Cardiovascular Event Lowering trial (EXSCEL) aimed to examine the risk associated with increasing number of diseased arterial beds on MACE and all-cause mortality (ACM). METHODS: Cox models were used to test associations between the number of diseased arterial beds and MACE and ACM. Prespecified interaction testing between number of diseased arterial beds with baseline HF, HbA1c (≤8% vs. >8%), and treatment assignment was performed. RESULTS: Overall, 14,751 participants were included; 26.5% were without atherosclerosis, 58.9% had 1-bed, 12.3% had 2-bed, and 2.3% had 3-bed disease. An increasing burden of atherosclerotic disease was associated with increasing risk of MACE (adjusted HR [aHR] 1.71 [95% CI 1.46-2.02]; 2.61 [2.17-3.15]; 3.46 [2.69-4.45] for 1, 2, and 3 beds, respectively, p < 0.001 for all) and ACM (1.94 [1.56-2.42]; 3.03 [2.33-3.95]; 3.66 [2.59-5.18] for 1, 2, and 3 beds, respectively, p < 0.001 for all). Prespecified interaction testing did not reveal any significant associations. CONCLUSIONS: In patients with T2D, compared to those without atherosclerotic vascular disease, risk of MACE and ACM increases incrementally with each additional diseased arterial bed.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Atherosclerosis

DOI

EISSN

1879-1484

Publication Date

December 2021

Volume

338

Start / End Page

1 / 6

Location

Ireland

Related Subject Headings

  • Risk Factors
  • Humans
  • Heart Failure
  • Exenatide
  • Diabetes Mellitus, Type 2
  • Cardiovascular System & Hematology
  • Cardiovascular System
  • Cardiovascular Diseases
  • 3202 Clinical sciences
  • 3201 Cardiovascular medicine and haematology
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Samsky, M. D., Mentz, R. J., Stebbins, A., Lokhnygina, Y., Aday, A. W., Pagidipati, N. J., … Gutierrez, J. A. (2021). Polyvascular disease and increased risk of cardiovascular events in patients with type 2 diabetes: Insights from the EXSCEL trial. Atherosclerosis, 338, 1–6. https://doi.org/10.1016/j.atherosclerosis.2021.10.011
Samsky, Marc D., Robert J. Mentz, Amanda Stebbins, Yuliya Lokhnygina, Aaron W. Aday, Neha J. Pagidipati, W Schuyler Jones, et al. “Polyvascular disease and increased risk of cardiovascular events in patients with type 2 diabetes: Insights from the EXSCEL trial.Atherosclerosis 338 (December 2021): 1–6. https://doi.org/10.1016/j.atherosclerosis.2021.10.011.
Samsky MD, Mentz RJ, Stebbins A, Lokhnygina Y, Aday AW, Pagidipati NJ, et al. Polyvascular disease and increased risk of cardiovascular events in patients with type 2 diabetes: Insights from the EXSCEL trial. Atherosclerosis. 2021 Dec;338:1–6.
Samsky, Marc D., et al. “Polyvascular disease and increased risk of cardiovascular events in patients with type 2 diabetes: Insights from the EXSCEL trial.Atherosclerosis, vol. 338, Dec. 2021, pp. 1–6. Pubmed, doi:10.1016/j.atherosclerosis.2021.10.011.
Samsky MD, Mentz RJ, Stebbins A, Lokhnygina Y, Aday AW, Pagidipati NJ, Jones WS, Katona BG, Patel MR, Holman RR, Hernandez AF, Gutierrez JA. Polyvascular disease and increased risk of cardiovascular events in patients with type 2 diabetes: Insights from the EXSCEL trial. Atherosclerosis. 2021 Dec;338:1–6.
Journal cover image

Published In

Atherosclerosis

DOI

EISSN

1879-1484

Publication Date

December 2021

Volume

338

Start / End Page

1 / 6

Location

Ireland

Related Subject Headings

  • Risk Factors
  • Humans
  • Heart Failure
  • Exenatide
  • Diabetes Mellitus, Type 2
  • Cardiovascular System & Hematology
  • Cardiovascular System
  • Cardiovascular Diseases
  • 3202 Clinical sciences
  • 3201 Cardiovascular medicine and haematology